Taylor Morrisette, Pharm.D., M.P.H.

home / authors / taylor-morrisette-pharm-d-m-p-h-

Medical University of Carolina School of Pharmacy

Articles

Expert commentary: A focus on RSV vaccination, mpox and HIV PrEP

Expert commentary: A focus on RSV vaccination, mpox and HIV PrEP

Taylor Morrisette, Pharm.D., M.P.H.
December 6th 2024

Numerous sessions spanned the field of infectious diseases at the IDWeek 2024 meeting. This expert commentary focuses on respiratory syncytial virus (RSV) vaccination, mpox and HIV pre-exposure prophylaxis (PrEP).

Read More

Latest Updated Articles

man looking at screen with gene images | ©muhammad stock.adobe.com
Published: December 10th 2024 | Updated: December 26th 2024
Next-Generation Testing Cheaper and More Effective for Guiding Lung Cancer Treatment
Pills balancing on top of each other | Image credit: James Thew - stock.adobe.com
Published: July 20th 2020 | Updated: December 26th 2024
For Better HCQ Retinopathy Guidelines, Include Prescribing Physicians
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
Published: October 3rd 2024 | Updated: December 26th 2024
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
Published: October 7th 2024 | Updated: December 26th 2024
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
Published: November 7th 2024 | Updated: December 26th 2024
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
Published: July 11th 2024 | Updated: December 26th 2024
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
© 2024 MJH Life Sciences

All rights reserved.